Antibiotic concentrations in saliva: A systematic review of the literature, with clinical implications for the treatment of sialadenitis

Journal of Oral and Maxillofacial Surgery

Volumn 72, Issue 1, 2014, Pages 67-75

  Troeltzsch, Matthias ^a   Pache, Christoph ^a   Probst, Florian Andreas ^a   Troeltzsch, Markus ^b   Ehrenfeld, Michael ^a   Otto, Sven ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; CEFADROXIL; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFOTIAM; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; PENICILLIN V; QUINOLONE DERIVATIVE; SPIRAMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC THERAPY; ARTICLE; BIOASSAY; DRUG SALIVA LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; SALIVATION; SIALOADENITIS; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW;

EID: 84890460096     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2013.06.214     Document Type: Review

References (66)

1. P.J. Bradley Benign salivary gland disease Hosp Med 62 2001 392
2. I. Brook, E.H. Frazier, and D.H. Thompson Aerobic and anaerobic microbiology of acute suppurative parotitis Laryngoscope 101 1991 170
3. I. Brook Aerobic and anaerobic microbiology of suppurative sialadenitis J Med Microbiol 51 2002 526
4. I. Brook Acute bacterial suppurative parotitis: Microbiology and management J Craniofac Surg 14 2003 37
5. I.I. Raad, M.F. Sabbagh, and G.J. Caranasos Acute bacterial sialadenitis: A study of 29 cases and review Rev Infect Dis 12 1990 591
6. P.J. Lamey, M.A. Boyle, and T.W. MacFarlane Acute suppurative parotitis in outpatients: microbiologic and posttreatment sialographic findings Oral Surg Oral Med Oral Pathol 63 1987 37
7. H. Maier, and M. Tisch [Bacterial sialadenitis] HNO 58 2010 229 (in German)
8. M.A. Lewis, P.J. Lamey, and J. Gibson Quantitative bacteriology of a case of acute parotitis Oral Surg Oral Med Oral Pathol 68 1989 571
9. Y. Akimoto, H. Nishimura, and M. Komiya Concentrations of ampicillin and cefadroxil in human serum and mixed saliva following a single oral administration of talampicillin and cefadroxil, and relationships between serum and mixed saliva concentrations Gen Pharmacol 16 1985 273
10. A. Heimdahl, L. Kager, and A.S. Malmborg Impact of different beta-lactam antibiotics on the normal human flora, and colonization of the oral cavity, throat and colon Infection 10 1982 120
11. A. Heimdahl, C.E. Nord, and K. Weilander Effect of bacampicillin on human mouth, throat and colon flora Infection 7 suppl 5 1979 S446
12. H. Maier, M. Zerfowski, and P. Schlegel [Excretion of beta-lactam antibiotics in human parotid saliva] HNO 39 1991 102 (in German)
13. W. Maier, and J. Strutz Concentration of cephalosporins in tissues of the head and neck after parenteral infusion Chemotherapy 41 1995 421
14. K.W. Stephen, J. McCrossan, and D. Mackenzie Factors determining the passage of drugs from blood into saliva Br J Clin Pharmacol 9 1980 51
15. C.F. Speirs Oral absorption and secretion of drugs Br J Clin Pharmacol 4 1977 97
16. A. Stjernquist-Desatnik, P. Samuelsson, and M. Walder Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis J Laryngol Otol 107 1993 309
17. H.F. Geerdes-Fenge, B. Goetschi, and M. Rau Comparative pharmacokinetics of dirithromycin and erythromycin in normal volunteers with special regard to accumulation in polymorphonuclear leukocytes and in saliva Eur J Clin Pharmacol 53 1997 127
18. E. Bergogne-Berezin Spiramycin concentrations in the human respiratory tract: A review J Antimicrob Chemother 22 suppl B 1988 117
19. A.M. Frydman, Y. Le Roux, and J.F. Desnottes Pharmacokinetics of spiramycin in man J Antimicrob Chemother 22 suppl B 1988 93
20. C.R. Smith The spiramycin paradox J Antimicrob Chemother 22 suppl B 1988 141
21. T.E. Rams, S. Dujardin, and J.D. Sautter Spiramycin resistance in human periodontitis microbiota Anaerobe 17 2011 201
22. N. Janin, H. Meugnier, and J.F. Desnottes Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers Antimicrob Agents Chemother 31 1987 1665
23. M. Mueller, H. Stass, and M. Brunner Penetration of moxifloxacin into peripheral compartments in humans Antimicrob Agents Chemother 43 1999 2345
24. G. Beyer, M. Hiemer-Bau, and S. Ziege Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora Eur J Clin Microbiol Infect Dis 19 2000 548
25. D.M. Livermore, D. James, and M. Reacher Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999 Emerg Infect Dis 8 2002 473
26. J.W. Decousser, B. Lamy, and P. Pina Trends in antibiotic susceptibility of bloodstream pathogens in hospitalized patients in France, 1996 to 2007 Diagn Microbiol Infect Dis 66 2010 292
27. D. Sakellari, J.M. Goodson, and A. Kolokotronis Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva J Clin Periodontol 27 2000 53
28. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
29. A. Strömberg, U. Friberg, and O. Cars Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid Eur J Clin Microbiol 6 1987 525
30. T.A. Najjar, K.M. Alkharfy, and S.Y. Saad Mechanism and implication of cephalosporin penetration into oropharyngeal mucosa J Infect Chemother 15 2009 70
31. G. Venetis, K. Chatzika, and G. Pitsiou Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery J Oral Maxillofac Surg 70 2012 1398
32. E. Grahn, and S.E. Holm Penicillin concentration in saliva and its influence on bacterial interference Scand J Infect Dis 19 1987 235
33. I. Adamsson, C.E. Nord, and P. Lundquist Comparative effects of omeprazole, amoxicillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients J Antimicrob Chemother 44 1999 629
34. J. Wust, and U. Hardegger Penetration of clarithromycin into human saliva Chemotherapy 39 1993 293
35. F. Koizumi, A. Ohnishi, and H. Takemura Effective monitoring of concentrations of ofloxacin in saliva of patients with chronic respiratory tract infections Antimicrob Agents Chemother 38 1994 1140
36. P.A. Rotzetter, A. Le Liboux, and E. Pichard Kinetics of spiramycin/metronidazole (Rodogyl) in human gingival crevicular fluid, saliva and blood J Clin Periodontol 21 1994 595
37. E.R. Pähkla, T. Koppel, and M. Saag Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis J Clin Periodontol 32 2005 163
38. E. Ragazzi, M. Fille, and P.A. Miglioli Saliva concentration of amoxicillin, erythromycin, and ciprofloxacin in outpatients: A comparison between the young and the elderly J Chemother 25 2013 126
39. S. Baglie, A.P. Del Ruenis, and R.H. Motta Plasma and salivary amoxicillin concentrations and effect against oral microorganisms Int J Clin Pharmacol Ther 45 2007 556
40. F. Kozjek, L.J. Suturkova, and G. Antolic Kinetics of 4-fluoroquinolones permeation into saliva Biopharm Drug Dispos 20 1999 183
41. C. Edlund, T. Bergan, and K. Josefsson Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics Scand J Infect Dis 19 1987 113
42. M.A. Van Oosten, F.J. Notten, and F.H. Mikx Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose J Dent Res 65 1986 1420
43. D. Adler, and H. Maier Gyrase inhibitor ciprofloxacin in human parotid saliva J Clin Chem Clin Biochem 27 1989 232
44. J.P. Maskell, A.M. Sefton, and H. Cannell Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycin J Antimicrob Chemother 26 1990 539
45. T. Hamada, E. Ueta, and H. Kodama The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities J Oral Pathol Med 31 2002 109
46. A. Mignot, M. Guillaume, and M. Brault Multiple-dose pharmacokinetics and excretion balance of gatifloxacin, a new fluoroquinolone antibiotic, following oral administration to healthy Caucasian volunteers Chemotherapy 48 2002 116
47. A. Orrling, C. Kamme, and A. Stjernquist-Desatnik Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute group A streptococcal pharyngotonsillitis Scand J Infect Dis 37 2005 429
48. E.A. Piercy, R.E. Bawdon, and P.A. Mackowiak Penetration of ciprofloxacin into saliva and nasal secretions and effect of the drug on the oropharyngeal flora of ill subjects Antimicrob Agents Chemother 33 1989 1645
49. F. Pehourcq, and C. Jarry Determination of third-generation cephalosporins by high-performance liquid chromatography in connection with pharmacokinetic studies J Chromatogr A 812 1998 159
50. S.M. Stewart, M. Fisher, and J.E. Young Ampicillin levels in sputum, serum, and saliva Thorax 25 1970 304
51. M. Zerfowski, P. Schlegel, and H. Maier Pharmacokinetics of cefotiam in plasma, parotid saliva and mixed saliva in healthy adults Arzneimittelforschung 41 1991 257
52. G. Alfter, N. Schwenzer, and D. Friess Perioperative antibiotic prophylaxis with cefuroxime in oral-maxillofacial surgical procedures J Craniomaxillofac Surg 23 1995 38
53. A. Bauernfeind, and R. Jungwirth Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil Infection 19 1991 353
54. A. Bauernfeind, R. Jungwirth, and E. Eberlein RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro J Antibiot (Tokyo) 45 1992 505
55. H.C. Neu, and K.P. Fu Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity Antimicrob Agents Chemother 13 1978 657
56. C.F. Speirs, D. Stenhouse, and K.W. Stephen Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin Br J Pharmacol 43 1971 242
57. M.G. Bergeron Tissue penetration of antibiotics Clin Biochem 19 1986 90
58. C.M. Eneroth, C. Lundberg, and L. Malmstrom Antibiotic concentrations in saliva of purulent parotitis Scand J Infect Dis 10 1978 219
59. O.G. Nilsen Pharmacokinetics of macrolides. Comparison of plasma, tissue and free concentrations with special reference to roxithromycin Infection 23 suppl 1 1995 S5
60. E. Bergogne-Berezin Clinical role of protein binding of quinolones Clin Pharmacokinet 41 2002 741
61. A. Andremont, C. Trancrede, and J.F. Desnottes Effect of oral spiramycin on the faecal and oral bacteria in human volunteers J Antimicrob Chemother 27 1991 355
62. P.B. Iannini The safety profile of moxifloxacin and other fluoroquinolones in special patient populations Curr Med Res Opin 23 2007 1403
63. J. Bertino Jr., and D. Fish The safety profile of the fluoroquinolones Clin Ther 22 2000 798
64. L. Mandell, and G. Tillotson Safety of fluoroquinolones: An update Can J Infect Dis 13 2002 54
65. R.C. Owens Jr., and P.G. Ambrose Torsades de pointes associated with fluoroquinolones Pharmacotherapy 22 2002 663
66. P. Pieroni, J. Goodfellow, and L. Reesor Antimicrobial susceptibilities of blood culture isolates obtained before and after the introduction of ciprofloxacin J Antimicrob Chemother 39 1997 419